Biohaven Pharmaceutical (NYSE:BHVN) reported quarterly losses of $(3.82) per share. This is a 45.8 percent decrease over losses of $(2.62) per share from the same period last year.
Uber Opposes Regulator Move For Boosting Fares Amid Driver Crisis, Surging Costs
Uber Technologies, Inc (NYSE: UBER) prosecuted the New York City Taxi & Limousine Commission (TLC) for approving a fare hike for ride-hail apps and taxi drivers amid driver shortage, rising operational costs, and higher inflation.
